Skip to content
Search

Latest Stories

Under-fire UK government rushes to build field hospitals as virus death toll surges

The UK government said on Friday (3) it was rushing to build more emergency field hospitals ahead of an expected surge in coronavirus cases, hours after recording a record 569 deaths from the disease.

Two new facilities will be built in Bristol in the west and Harrogate in the north to house up to 1,500 patients, the NHS said in a statement.


The announcement comes as a similar 4,000-bed facility in London -- built in less than ten days -- prepares to open Friday, and as criticism mounts over the government's failure to provide screening, particularly for frontline healthcare workers.

"Further such hospitals will open next in Birmingham and Manchester, offering up to 3,000 beds between them," the NHS statement added.

The health ministry announced a record 569 deaths from the virus in Britain in the 24 hours up to 1600 GMT on Wednesday -- the largest single-day rise yet.

It followed 563 deaths over the previous corresponding period.

Prime minister Boris Johnson has said Britain will "massively increase testing" for the COVID-19 virus following criticism of his initial light-touch approach to the outbreak.

Johnson has been in self-isolation "with mild symptoms" at his Downing Street official residence since announcing on March 27 that he had caught the virus.

Heir to the throne Prince Charles Thursday made his first public comments since coming out of self-quarantine after contracting the disease, telling the PA news agency the experience had been "strange, frustrating and often distressing".

In a video message, he praised the "utter, selfless devotion to duty" of Britain's health workers.

The country took part in another collective round of applause at 8:00 pm (2000 GMT) Thursday, with social media videos capturing cheers across its cities, towns and villages.

- Growing backlash -

Johnson is facing criticism even in normally supportive media outlets after officials revealed that just 2,000 out of about 500,000 NHS staff had been tested.

Health minister Matt Hancock said Thursday the government was "determined" to scale up tests across the board in the coming weeks, with a "goal of 100,000 tests per day by the end of this month".

Hancock blamed global demand for swabs and reagents for the lack of tests, and said that some they had bought were faulty.

In order to meet the demand, the government said it would work with private firms such as Amazon and chemist Boots, and that three new "mega labs" would soon be online.

Testing for the general public has also been criticised as not widespread enough and is currently largely limited to hospital admissions of the most serious COVID-19 patients.

On Tuesday, 10,000 hospital patients and NHS staff were tested in England, well below the daily target of 25,000 and the 70,000 a day achieved in Germany, which has been used as a comparison.

Paul Nurse, chief executive of biomedical research centre the Francis Crick Institute, told the BBC Thursday that the government should summon "the Dunkirk spirit" and let "small ship" labs start screening for the killer disease.

So far, Public Health England (PHE), the body tasked with testing, has insisted all screening should be carried out centrally.

PHE medical director Professor Paul Cosford defended his organisation's work.

"At the very outset we identified this, we got the tests in place, we designed the tests in our laboratories. We have played our part," he told BBC radio.

Britain is currently in the second week of a three-week lockdown, with non-essential shops shut and the public asked to stay at home to try to limit the spread of the coronavirus.

The government has promised an enormous package of support for businesses and employees hit by the measures.

New government figures show 950,000 people applied for state welfare support known as universal credit in the last two weeks. It is available to the unemployed and those on low incomes.

With economic headwinds gathering pace, national carrier British Airways is also to temporarily lay off 28,000 staff, the union representing its workers announced Thursday.

Hancock, meanwhile, demanded that English Premier League footballers take a pay cut amid outrage at top flight clubs using a government furlough scheme for non-playing staff.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less